Cardiovascular disease in type 2 diabetes

被引：23

作者：

Bloomgarden, ZT ^{[1
]}

机构：

[1] Mt Sinai Sch Med, Div Endocrinol, New York, NY 10029 USA

来源：

DIABETES CARE | 1999年 / 22卷 / 10期

关键词：

D O I：

10.2337/diacare.22.10.1739

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：1739 / 1744

页数：6

共 51 条

[1]

Alderman EL, 1996, NEW ENGL J MED, V335, P217

[2] THE EFFECT OF CHOLESTEROL-LOWERING AND ANTIOXIDANT THERAPY ON ENDOTHELIUM-DEPENDENT CORONARY VASOMOTION [J].

ANDERSON, TJ ;

MEREDITH, IT ;

YEUNG, AC ;

FREI, B ;

SELWYN, AP ;

GANZ, P .

NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (08) :488-493

[3]

Bazzino O, 1998, NEW ENGL J MED, V338, P1488

[4] Final outcome results of the multicenter isradipine diuretic atherosclerosis study (MIDAS) - A randomized controlled trial [J].

Borhani, NO ;

Mercuri, M ;

Borhani, PA ;

Buckalew, VM ;

CanossaTerris, M ;

Carr, AA ;

Kappagoda, T ;

Rocco, MV ;

Schnaper, HW ;

Sowers, JR ;

Bond, MG .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (10) :785-791

[5] Plasminogen activator inhibitor-1 activity is independently related to both insulin sensitivity and serum triglycerides in 70-year-old men [J].

Byberg, L ;

Siegbahn, A ;

Berglund, L ;

McKeigue, P ;

Reneland, R ;

Lithell, H .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1998, 18 (02) :258-264

[6] Isradipine, raised glycosylated haemoglobin, and risk of cardiovascular events [J].

Byington, RP ;

Craven, TE ;

Furberg, CD ;

Pahor, M .

LANCET, 1997, 350 (9084) :1075-1076

[7] USE OF A MONOCLONAL-ANTIBODY DIRECTED AGAINST THE PLATELET GLYCOPROTEIN IIB/IIIA RECEPTOR IN HIGH-RISK CORONARY ANGIOPLASTY [J].

CALIFF, RM ;

SHADOFF, N ;

VALETT, N ;

BATES, E ;

GALEANA, A ;

KNOPF, W ;

SHAFTEL, J ;

BENDER, MJ ;

AVERSANO, T ;

RAQUENO, J ;

GURBEL, P ;

COWFER, J ;

COHEN, M ;

CROSS, P ;

BITTL, J ;

EDDINGS, K ;

TAYLOR, M ;

DEROSA, K ;

HATTEL, L ;

COOPER, L ;

ESHELMAN, B ;

FINTEL, D ;

NIEMYSKI, P ;

KLEIN, L ;

KENNEDY, H ;

THORNTON, T ;

KEREIAKES, D ;

MARTIN, L ;

ANDERSON, L ;

HIGBY, N ;

ELLIS, S ;

BREZINA, K ;

GEORGE, B ;

CHAPEKIS, A ;

SMITH, D ;

ANWAR, A ;

GERBER, TL ;

PRITCHARD, GL ;

MYLER, R ;

SHAW, R ;

MURPHY, M ;

WARD, K ;

MADIGAN, NP ;

BLANKENSHIP, J ;

HALBERT, M ;

FLANAGAN, C ;

TANNENBAUM, M ;

POLICH, M ;

STEVENSON, C ;

TCHENG, J .

NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (14) :956-961

[8] Platelet GPIIb/IIIa antagonists: The first anti-integrin receptor therapeutics [J].

Coller, BS .

JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (07) :1467-1471

[9] PREVALENCE OF TOTAL CORONARY-OCCLUSION DURING THE EARLY HOURS OF TRANSMURAL MYOCARDIAL-INFARCTION [J].

DEWOOD, MA ;

SPORES, J ;

NOTSKE, R ;

MOUSER, LT ;

BURROUGHS, R ;

GOLDEN, MS ;

LANG, HT .

NEW ENGLAND JOURNAL OF MEDICINE, 1980, 303 (16) :897-902

[10] SUDDEN CARDIAC DEATH WITHOUT WARNING - POSSIBLE MECHANISMS AND IMPLICATIONS FOR SCREENING ASYMPTOMATIC POPULATIONS [J].

EPSTEIN, SE ;

QUYYUMI, AA ;

BONOW, RO .

NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (05) :320-324

← 1 2 3 4 5 6 →